3 Reasons to Avoid OLPX and 1 Stock to Buy Instead
Olaplex has gotten torched over the last six months - since October 2024, its stock price has dropped 45.5% to $1.14 per share. This may have investors wondering how to approach the situation.
Pharmaceuticals Stocks Q4 In Review: Jazz Pharmaceuticals (NASDAQ:JAZZ) Vs Peers
Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look at Jazz Pharmaceuticals (NASDAQ:JAZZ) and its peers.
Q4 Rundown: EnerSys (NYSE:ENS) Vs Other Renewable Energy Stocks
As the Q4 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the renewable energy industry, including EnerSys (NYSE:ENS) and its peers.
Building Materials Stocks Q4 Recap: Benchmarking Carlisle (NYSE:CSL)
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q4. Today, we are looking at building materials stocks, starting with Carlisle (NYSE:CSL).
3 Reasons INGM is Risky and 1 Stock to Buy Instead
Shareholders of Ingram Micro would probably like to forget the past six months even happened. The stock dropped 33.8% and now trades at $16.29. This was partly due to its softer quarterly results and might have investors contemplating their next move.
Q4 Rundown: Keurig Dr Pepper (NASDAQ:KDP) Vs Other Beverages, Alcohol, and Tobacco Stocks
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Keurig Dr Pepper (NASDAQ:KDP) and the best and worst performers in the beverages, alcohol, and tobacco industry.
Q4 Rundown: Sea (NYSE:SE) Vs Other Online Marketplace Stocks
As the Q4 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the online marketplace industry, including Sea (NYSE:SE) and its peers.
Healthcare Technology Stocks Q4 In Review: Hims & Hers Health (NYSE:HIMS) Vs Peers
Let’s dig into the relative performance of Hims & Hers Health (NYSE:HIMS) and its peers as we unravel the now-completed Q4 healthcare technology earnings season.
Traditional Fast Food Stocks Q4 In Review: Yum! Brands (NYSE:YUM) Vs Peers
Looking back on traditional fast food stocks’ Q4 earnings, we examine this quarter’s best and worst performers, including Yum! Brands (NYSE:YUM) and its peers.
Outpatient & Specialty Care Stocks Q4 Teardown: Select Medical (NYSE:SEM) Vs The Rest
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q4. Today, we are looking at outpatient & specialty care stocks, starting with Select Medical (NYSE:SEM).